Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 700-862-4 | CAS number: 42797-18-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in chemico
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 017
- Report date:
- 2017
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 442C (In Chemico Skin Sensitisation: Direct Peptide Reactivity Assay (DPRA))
- Deviations:
- yes
- Remarks:
- Precipitates of the test substance were observed at the end of the incubation with the peptides, therefore the peptide depletion may be underestimated.
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- direct peptide reactivity assay (DPRA)
Test material
- Reference substance name:
- 2-{[1,1'-biphenyl]-4-carbonyl}benzoic acid
- EC Number:
- 700-862-4
- Cas Number:
- 42797-18-2
- Molecular formula:
- C20 H14 O3
- IUPAC Name:
- 2-{[1,1'-biphenyl]-4-carbonyl}benzoic acid
- Test material form:
- solid: particulate/powder
Constituent 1
In chemico test system
- Details on the study design:
- Reactivity (expressed as percent of peptide depletion) is determined following 24-h contact between the test substance and peptide in acetonitrile at the ratios 1:10 cysteine: test substance and 1:50 lysine: test substance by liquid chromatography with UV-Visible spectra detection.
The reactivity of the test substance was evaluated in chemico by monitoring peptide depletion following a 24-hour contact between the test substance and synthetic cysteine and lysine peptides. The method consisted of the incubation of a diluted solution of cysteine or lysine with the test substance for 24 hours. At the end of the incubation, the concentrations of residual peptides were evaluated by HPLC with Ultra-Violet detection at 220 nm. Peptide reactivity was reported as percent depletion based on the peptide peak area of the replicate injection and the mean peptide peak area in the three relevant reference control C samples (in the appropriate solvent).
% depletion = 1- (Peptide peak area in replicate injection/Mean peptide peak area in relevant reference control C samples) x 100
The test substance was dissolved at 100 mM in a 1:9 mixture of DMSO : acetonitrile. The acceptance criteria for the calibration curve samples, the reference and positive controls as well as for the study samples were satisfied. The study was therefore considered to be valid. Analysis of the chromatograms of the co-elution samples indicated that the test substance did not co-elute with either the lysine or the cysteine peptides.
Analytical analysis:
- High Performance Liquid Chromatography (HPLC) Systems with a UV detector (220 nm),
- analytical chromatographic columns (Zorbax SB C18, 100 x 2.1 mm; 3.5 μm HPLC), in-line filter C18, 4.0 x 2.0 mm (Phenomenex)
Mobile phases run in gradient:
A: acetonitrile + 0.085 % TFA
B: milli-Q water + 0.1% TFA
Flow: 350 μL/minute
Oven temperature: 30.0 °C
Autosampler temperature: nominal temperature: +25 °C
Injection volume: 5 μL
Total analysis time: 20 minutes
Co-elution control samples preparation:
For the co-elution control with cysteine peptide: 50 μL of test substance formulation was incubated with 750 μL of cysteine peptide dilution buffer (without cysteine peptide) and 200 μL of acetonitrile.
For the co-elution control with lysine peptide: in parallel, 250 μL of test substance formulation was incubated with 750 μL of lysine peptide dilution buffer (without lysine peptide).
Reference control samples preparation:
Reference control A and B samples: In a vial, acetonitrile was added to a volume of peptide solution (cysteine or lysine) to achieve a nominal concentration of 0.500 mM.
Reference control C samples:
Reference control C samples were prepared for each solvent used to dissolve the test and positive control substances.
For the reference control C prepared with cysteine peptide:
50 μL of each vehicle (a 1:9 mixture of DMSO:acetonitrile or acetonitrile) was incubated with 750 μL of cysteine peptide solution (at 0.667 mM in phosphate buffer at pH 7.5) and 200 μL of acetonitrile.
For the reference control C prepared with lysine peptide:
In parallel, 250 μL of each vehicle (a 1:9 mixture of DMSO:acetonitrile or acetonitrile) was incubated with 750 μL of lysine peptide solution (at 0.667 mM in ammonium acetate buffer at pH 10.2).
Cinnamaldehyde (positive control) depletion control samples preparation:
For the reactivity of cinnamaldehyde with cysteine peptide:
50 μL of cinnamaldehyde at 100 mM in acetonitrile was incubated with 750 μL of cysteine peptide solution (at 0.667 mM in phosphate buffer at pH 7.5) and 200 μL of acetonitrile.
For the reactivity of cinnamaldehyde with lysine peptide:
In parallel, 250 μL of cinnamaldehyde at 100 mM in acetonitrile was incubated with 750 μL of lysine peptide solution (at 0.667 mM in ammonium acetate at pH 10.2).
Test substance samples preparation:
For the reactivity of test substance with cysteine peptide:
50 μL of test substance formulation was incubated with 750 μL of cysteine peptide solution (at 0.667 mM in phosphate buffer at pH 7.5) and 200 μL of acetonitrile.
For the reactivity of substance with lysine peptide:
In parallel, 250 μL of test item formulation was incubated with 750 μL of lysine peptide solution (at 0.667 mM in ammonium acetate at pH 10.2).
Preparation of the calibration curve samples:
One set of calibration standards was prepared with each analytical sequence by spiking each peptide (lysine and cysteine) in separate solutions of 20 % acetonitrile:peptide dilution buffer to obtain at least six different concentration levels ranging from 0.0167 to 0.534 mM. A dilution buffer blank was also included in the standard calibration curve.
Skin sensitisation (In chemico test system) - Details on study design:
Placeholder - no text template available yet
Results and discussion
- Positive control results:
- The positive control was cinnamaldehyde (purity: 98.9%).
As several test items were assayed concurrently, the results of the positive control were shared.
The positive control was pre-weighed and stored under appropriate conditions until ready to perform testing. It was dissolved in acetonitrile at 100 mM. The physical aspect of the formulation was clear colorless solution. The formulation was used just after its preparation.
In vitro / in chemico
Results
- Key result
- Parameter:
- other: mean of the percent cysteine and percent lysine depletion
- Value:
- 0.97
- Vehicle controls validity:
- valid
- Remarks:
- 1:9 mixture of DMSO:acetonitrile
- Negative controls validity:
- valid
- Remarks:
- co-elution control samples
- Positive controls validity:
- valid
- Remarks:
- cinnamaldehyde
- Remarks on result:
- no indication of skin sensitisation
- Other effects / acceptance of results:
- DATA ANALYSIS
Calculation of the percent peptide depletion
Each appropriate peak was integrated and the peak area for calibration standards, control and test substance samples were determined. Based on the concentration of standards and their peak area, a linear calibration curve was generated. Then, the concentration of peptide was determined in each sample from absorbance at 220 nm, measuring the peak area of the appropriate peaks and calculating the concentration of peptide using the linear calibration curves. Then, for each positive control and test substance replicate, the percent depletion of peptide was determined from the peptide peak area of the replicate injection and the mean peptide peak area in the three relevant reference control C samples (in the appropriate solvent) by using the following formula:
% depletion = 1- (Peptide peak area in replicate injection/Mean peptide peak area in relevant reference control C samples) x 100
Then, the mean percent depletion of the three replicates was calculated for each peptide as well as the mean of the percent cysteine and percent lysine depletions. Negative depletion values were considered as "Zero" for the calculation of the mean %depletion.
Evaluation of the possible co-elution of the test substance with the lysine or cysteine peptides:
In order to detect possible co-elution of the test substance with a peptide, chromatograms of the co-elution control samples were analyzed and compared with those of the reference control C samples.
ACCEPTANCE CRITERIA
The run was considered valid if the following criteria were fully met:
. the calibration curve should have a coefficient of determination (r2) ≥ 0.99,
. the mean peptide concentrations of the reference control A samples should be within ± 10 % of the nominal concentration,
. the cinnamaldehyde depletion control samples should meet the following acceptance criteria:
− for the cysteine peptide, the mean percent depletion value should be between 60.8 and 100 % with a SD < 14.9%,
− for the lysine peptide, the mean percent depletion value should be between 40.2 and 69.0 % with a SD < 11.6%,
. the CV of the mean peptide peak area of the nine reference control B and C samples in acetonitrile must be < 15.0%.
The test substance results were considered valid if the following criteria were fully met:
. the mean peptide concentrations of the reference control C samples prepared in the appropriate solvent should be within ± 10% of the nominal concentration,
. the maximum SD for the test substance replicates should be < 14.9% for the percent cysteine depletion value and < 11.6% for the percent lysine depletion value.
Any other information on results incl. tables
The cysteine peptide depletion value was 1.21%,
The lysine peptide depletion value was 0.72%.
The mean of the percent cysteine and percent lysine depletions was equal to 0.97%. However, since precipitates were observed at the end of the incubation with the peptides, the peptide depletion may be underestimated.
Since the mean of the percent cysteine and percent lysine depletions was < 6.38%, the test substance was considered to have minimal peptide reactivity. Therefore, the DPRA prediction is considered as negative and the test substance is likely not to have any potential to cause skin sensitization, though with limitations due to test substance precipitation with the peptides.
Applicant's summary and conclusion
- Interpretation of results:
- other: Negative
- Conclusions:
- Under the study conditions, the test substance was considered to have no/minimal peptide reactivity, although with limitations due to test substance precipitation with the peptides. Therefore, the test substance is considered to produce negative results in the DPRA assay.
- Executive summary:
A study was conducted to determine the reactivity potential of the test substance PBBA, with synthetic cysteine and lysine peptides according to OECD Guideline 442 C (direct peptide reactivity assay (DPRA)), in compliance with GLP. The method consisted of the incubation of a diluted solution of cysteine or lysine with the test substance for 24 h at the ratios 1:10 cysteine: test substance and 1:50 lysine: test substance. The test substance was dissolved at 100 mM in a 1:9 mixture of DMSO : acetonitrile. At the end of the incubation, the concentrations of residual peptides were evaluated by HPLC with UV detection at 220 nm.Peptide reactivity was reported as percent depletion based on the peptide peak area of the replicate injection and the mean peptide area in the three relevant reference control C samples. Results of the test substance reactivity indicated for the cysteine peptide, the mean depletion value of 1.21% and for the lysine peptide, the mean depletion value of 0.72%. The mean of the percent cysteine and percent lysine depletions was equal to 0.97%. However, since precipitates were observed at the end of the incubation with the peptides, depletion may be underestimated. Since the mean of the percent cysteine and percent lysine depletions was <6.38%, the test substance was considered to have no/minimal peptide reactivity. The acceptance study criteria were satisfied, the study was therefore considered to be valid. Under the study conditions, the test substance was considered to have no/minimal peptide reactivity, although with limitations due to test substance precipitation with the peptides. Therefore, the test substance was considered to produce negative results in the DPRA assay (Chevallier, 2017).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.